Dr. Christopher Lee Downing, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1787 W Lee Hwy Ste 3, Wytheville, VA 24382 Phone: 276-228-1050 Fax: 855-352-6646 |
Dalkeith George Facey, D.O. MBA Surgery Medicare: Accepting Medicare Assignments Practice Location: 305 Spring Meadow Dr, Wytheville, VA 24382 Phone: 917-626-3666 |
James Christopher Zwanch, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 590 W Ridge Rd, Suite D, Wytheville, VA 24382 Phone: 570-498-2799 |
Susan Cash, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 590 W Ridge Rd Ste M, Wytheville, VA 24382 Phone: 276-625-8870 Fax: 276-228-2010 |
News Archive
NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system disorders, today announced the start of patient enrollment in a long-term safety study (trial 012) of the company's continuously administered subcutaneous levodopa/carbidopa formulation used in both ND0612H and ND0612L.
A policy of single embryo transfer (SET) reduces the risk of perinatal mortality in infants born as a result of IVF and ICSI. The conclusion emerged from an analysis of more than 50,000 births recorded in the Australian and New Zealand Assisted Reproduction Technology Database between 2004 and 2008, where the introduction of an SET policy has been associated with a reduction in overall perinatal mortality for IVF and ICSI babies.
Using advanced MRI and an artificial intelligence technique, researchers in Geneva, Switzerland, have identified a method that may help identify which individuals with mild cognitive impairment (MCI) will continue to decline, according to a study published online and in the December issue of Radiology.
Solving Kids' Cancer, the Neuroblastoma Children's Cancer Alliance (NCCA UK), and Joining Against Cancer in Kids (J-A-C-K) awarded its first grant through their INBRACED (International Neuroblastoma Research and Collaboration for Effective Delivery) initiative, which aims to improve access of promising clinical trials for children with high-risk neuroblastoma in North America, the UK and in Europe.
› Verified 4 days ago